Abstract
The clinical outcome of 21 adults with ALL1(MLL)/AF4 positive acute lymphoblastic leukemia enrolled in the GIMEMA LAL 2000 trial and of 25 patients entered into the previous 0496 study is reported. LAL 2000 included more intensive consolidation and transplants. Complete remission rates were 90% and 88% in the LAL 2000 and 0496 trials, respectively. Fifteen patients were transplanted (5 autologous, 10 allogeneic). At 36 months, overall and disease free survivals were 32.9%, 31.8%, 28% and 27.3%, in LAL 2000 and 0496 trials, respectively. Relapses remained the main reason of failure occurring in 10 and 16 of the 19 and 22 responding patients. In the LAL 2000 study, 4 relapses were observed before transplant. Thus, ALL1(MLL)/AF4 abnormality characterized a subset of patients with adverse prognosis in which the overall strategy adopted in the LAL 2000 study, rather than transplants per se, failed to improve the patient clinical outcome.
References
Aug 1, 1976·British Journal of Haematology·J M BennettC Sultan
Oct 1, 1992·Nature Genetics·M DjabaliG A Evans
Nov 13, 1992·Cell·D C TkachukM L Cleary
Nov 13, 1992·Cell·Y GuE Canaani
Dec 11, 1991·Proceedings of the National Academy of Sciences of the United States of America·S Ziemin-van der PoelJ D Rowley
Apr 1, 1987·Analytical Biochemistry·P Chomczynski, N Sacchi
Jun 1, 1994·Baillière's Clinical Haematology·W D LudwigE Thiel
Feb 3, 1994·The New England Journal of Medicine·M J Cline
Nov 14, 1997·Science·A T Look
Jan 25, 2002·Blood·Luciana AnninoUNKNOWN GIMEMA Group
Jul 19, 2002·Cancer Cell·D Gary Gilliland, Martin S Tallman
Jun 7, 2003·Blood·Giuseppe CiminoUNKNOWN GIMEMA Group
Jan 15, 2005·Blood·Marco ManciniRobin Foà
Dec 14, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masamitsu YanadaUNKNOWN Japan Adult Leukemia Study Group
Apr 28, 2006·Blood·Barbara WassmannOliver G Ottmann
Oct 14, 2006·Leukemia·N VeyUNKNOWN GET-LALA Group the Swiss Group for Clinical Cancer Research (SAKK)
Oct 26, 2006·Blood·Adrienne de LabartheUNKNOWN Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Dec 16, 2006·Blood·Anthony V MoormanUNKNOWN Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute
Citations
Dec 23, 2011·Advances in Hematology·F MarchesiG Avvisati
Sep 29, 2011·American Journal of Hematology·Loredana EliaGiuseppe Cimino
Feb 18, 2016·Oncotarget·Monica MessinaRobin Foà
May 29, 2021·American Journal of Hematology·Alfonso PiciocchiMarco Vignetti